Génome Québec allocates $ 1,9 M to the OPTITHERA project.

December 12, 2023

Génome Québec is particularly proud of the performance of Québec teams in a pan-Canadian competition. Over $23 million will be invested in genomics in Québec, including $5.4 million through Génome Québec. In fact, 49% of the available Canadian envelope was allocated to Québec projects. These investments will accelerate the commercialization and increase its real-world applications.

Contact us

Interested in learning more about the
OPTITHERA test?

Call us at 514-890-8247

or send us an email at
info@optithera.onmicrosoft.com

900 Saint-Denis Street, Suite R14.404
Montreal, Quebec, Canada  H2X 0A9

Alert me as soon as the Optithera test is available.

Abonnement - Anglais

Upcoming test

Polygenic risk score for cardiorenal risk in subjects with type-2 diabetes